THE RECORD / WHAT'S PUBLISHED
Melanotan 2 research: a small, specific literature, read straight
The mechanism is well worked out. The human data is tiny. The safety signal lives in case reports. Here's the whole record, cited.
Before the details
Here's the short version of the Melanotan 2 research. The mechanism is the solid part: Melanotan 2 mimics a natural hormone (alpha-MSH) and switches on a family of receptors called melanocortin receptors. Hit the one on pigment cells (MC1R) and the skin makes more dark pigment, so it tans without sun. Hit the ones in the brain (MC4R, MC3R) and you get the appetite drop and the erection effects. The human evidence is small: a 3-man tanning pilot and a 10-man erectile-function study, both from the 1990s [3][4]. After that, it's animal studies and chemistry papers — plus a long line of case reports describing harms. No big trial was ever finished [1]. We'll glossary the jargon as we go: a receptor is a docking port on a cell, and an agonist is a molecule that docks and switches it on.
What is melanotan 2?
Melanotan 2 is a synthetic melanocortin peptide — a small, lab-made protein modeled on alpha-melanocyte-stimulating hormone (alpha-MSH), the body's own pigment-stimulating signal [29]. Chemically it's a cyclic (ring-shaped) heptapeptide, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, molecular formula C50H69N15O9, molecular weight about 1024.2 Da, CAS 121062-08-6. It was designed in the late 1980s by Victor Hruby, Mac Hadley, and colleagues at the University of Arizona to be more potent and longer-lasting than natural alpha-MSH — the ring structure (a lactam bridge) is what makes it resist the enzymes that would normally chew it up [29][8]. Unlike its cousin afamelanotide, which is fairly selective for the pigment receptor, Melanotan 2 is non-selective: it activates all the melanocortin receptors (MC1R through MC5R), which is exactly why its effects spill across tanning, appetite, and sexual function [13].
Melanotan: the MC1R-cAMP-MITF tanning cascade
The tanning mechanism is the best-understood thing about melanotan. When the peptide docks on MC1R on a pigment cell, it raises a messenger molecule inside the cell called cAMP. cAMP kicks off a relay — PKA, then CREB, then a master switch called MITF — that turns up the gene for tyrosinase, the rate-limiting enzyme of pigment production [13]. The net effect: more eumelanin (the dark, protective brown-black pigment) and a tan that doesn't need UV to start. This is the same endogenous pathway alpha-MSH uses; Melanotan 2 just pushes it harder and for longer [29]. Because pigment synthesis keeps running after the peptide clears, the color can persist for weeks. The detailed receptor biology was characterized across decades of melanocortin pharmacology [13].
MT2 in humans: the two studies that exist
The controlled human record for mt2 is two small studies. The 1996 pilot was single-blind and placebo-controlled in three healthy men: subcutaneous doses escalated from 0.01 to 0.025-0.03 mg/kg every other weekday for two weeks. Two of three men showed measurable facial, upper-body, and buttock darkening after only five low doses, with spontaneous erections lasting one to five hours, mild nausea, and dose-limiting drowsiness at the top dose [3]. The 1998 study was a double-blind placebo-controlled crossover in ten men with psychogenic erectile dysfunction at 0.025 mg/kg: eight of ten developed clinically apparent erections, with mean rigidity time of 38.0 minutes versus 3.0 minutes on placebo, alongside transient nausea, stretching, and yawning that needed no treatment [4]. These doses are study facts, reported to document what was administered to research subjects — not dosing recommendations. Melanotan 2 is not approved for human use. No Phase II or III trial has ever followed [1].
Melanotan ii in animals: appetite and the brain
Beyond pigment, melanotan ii has been studied mostly in rodents for its effects on appetite and behavior. In male mice, the compound microinjected directly into the nucleus accumbens — a brain region central to reward and motivation — at 0.1 to 1 nmol per side significantly cut both food consumption and the effort animals would put in to get food, and it did so without causing taste aversion or changing metabolic rate [7]. That's a clean result: the appetite effect looks like genuine reduced food motivation, not sickness. This central melanocortin signaling, via MC4R and MC3R, is the same machinery the human appetite reports point to — though no controlled human weight-loss trial of Melanotan 2 exists.
The safety literature: case reports, not trials
The harm record is built almost entirely from case reports, which matters: case reports show that something can happen, not how often. A 2020 nephrology paper described renal infarction most likely caused by Melanotan 2 and noted that rhabdomyolysis with renal failure had been reported before [9]. A 2009 report linked a change in moles to an unlicensed 'sun-tan jab' [10]. A 2021 qualitative study of online forums catalogued nausea, flushing, changing skin lesions, and sourcing risk as the dominant user concerns [12], and a 2026 case report documented reversible darkening of the mouth's lining after self-injection over 64 days [31]. Older work established the analytical methods to detect and quantify the peptide in plasma and urine [8][32]. The pattern is consistent across decades: real effects, real harms in individuals, no controlled long-term safety data.
Regulatory and historical context
A 2006 review of melanocortin therapeutics traces the lineage cleanly: the linear analog Melanotan I was tested for tanning, the cyclic Melanotan 2 for erectile dysfunction, and a further MT-2-derived analog — bremelanotide (PT-141) — advanced toward approval for sexual dysfunction [1][33]. Of that family, only afamelanotide (Melanotan I) reached approval for the rare disorder erythropoietic protoporphyria, where a long-term study of 115 patients on repeated implants reported sustained quality-of-life gains with mostly minor side effects [5]. Melanotan 2 itself never crossed the approval line in any country and is now an unregulated research chemical, repeatedly flagged by dermatology bodies and tracked in forensic drug surveys [28][11]. That regulatory story is the spine of this site — see is melanotan 2 safe and melanotan 2 dangers.